Free Trial
OTCMKTS:LBTSF

Almirall (LBTSF) Stock Price, News & Analysis

Almirall logo
$9.01 0.00 (0.00%)
As of 04/30/2025

About Almirall Stock (OTCMKTS:LBTSF)

Key Stats

Today's Range
$9.01
$9.01
50-Day Range
$9.01
$9.01
52-Week Range
$9.01
$9.17
Volume
N/A
Average Volume
200 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Almirall, S.A., a biopharmaceutical company, engages in the purchase, manufacture, storage, and sale of skin-health medicines in Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising actinic keratosis, atopic dermatitis, alopecia areata, skin cancer, psoriasis, onychomycosis, vitiligo, hidradenitis suppurativa, oncodermatology, acne, orphan indications, and rare skin diseases, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, respiratory, and nervous system; dermatologicals; genito urinary system and sex hormones; immunostimulants; and systematic hormonal preparations. It has a multi-target alliance with Etherna to research and develop new mRNA-based therapies for severe skin diseases, including non-melanoma skin cancer. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain.

Receive LBTSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Almirall and its competitors with MarketBeat's FREE daily newsletter.

LBTSF Stock News Headlines

Jefferies Keeps Their Buy Rating on Almirall (0O9B)
Musk's warning signal: Prepare before the cascade begins
When Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t. With 40+ years of market modeling, he says Musk’s move wasn’t about efficiency — it was a signal. And what’s coming next could divide the market into winners and losers faster than anyone expects. Watch this urgent video briefing now.
Kepler Capital Reaffirms Their Buy Rating on Almirall (0O9B)
Almirall (0O9B) Gets a Buy from RBC Capital
Almiralll, S.A. (LBTSF) Q4 2024 Earnings Call Transcript
See More Headlines

LBTSF Stock Analysis - Frequently Asked Questions

Almirall's stock was trading at $9.1730 at the beginning of the year. Since then, LBTSF stock has decreased by 1.8% and is now trading at $9.01.
View the best growth stocks for 2025 here
.

Shares of LBTSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
5/01/2025
Next Earnings (Estimated)
5/12/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
OTCMKTS:LBTSF
CIK
N/A
Fax
N/A
Employees
1,996
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (OTCMKTS:LBTSF) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners